Efficacy and Safety of Bimatoprost Sustained-Release (SR) in Patients With Open-Angle Glaucoma or Ocular Hypertension
Study Identifier
192024-092
CT.gov Identifier
EudraCT Identifier
EUCTIS ID
Not available
For general inquiries, please contact
Study Complete
Results Available
Protocol
Available Language(s): English
Statistical Analysis Plan
Available Language(s): English
Plain Language Summary
Available Language(s): English, Czech, Italian, Spanish, Turkish, Zulu
Study Details
Medical Condition
Study Drug
Phase
Phase 3
Sex
Female & Male
Age
18+ years
Protocol Summary
This study will evaluate the efficacy and safety of bimatoprost sustained-release (SR) in patients with open-angle glaucoma or ocular hypertension. The study includes a 12-month treatment period with an 8-month extended follow-up.
Study Locations
Location
Status
Location
Eye Center South
Dothan, Alabama, United States, 36301
Status
Not applicable
Location
Arizona Eye Center
Chandler, Arizona, United States, 85224
Status
Not applicable
Location
Vold Vision
Fayetteville, Arkansas, United States, 72704
Status
Not applicable
Location
Mark B. Kislinger, MD, Inc.
Glendora, California, United States, 91741
Status
Not applicable
Location
Inland Eye Specialists
Hemet, California, United States, 92545
Status
Not applicable
Location
Southern California Eye Physicians and Surgeons
Los Alamitos, California, United States, 90720
Status
Not applicable
Showing {first} - {last} of {total} Results